Does creatine supplementation raise serum creatinine levels, indicating impaired renal function, in individuals with normal baseline kidney function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Creatine Supplementation and Serum Creatinine

Creatine supplementation does raise serum creatinine levels, but this elevation does NOT indicate impaired renal function—it reflects increased creatine metabolism, not kidney damage.

Understanding the Mechanism

The key distinction here is between creatinine as a metabolic byproduct versus creatinine as a marker of kidney injury. Creatine is spontaneously and non-enzymatically converted to creatinine in muscle tissue 1. When you supplement with creatine, you increase the substrate pool, which naturally leads to more creatinine production through normal metabolism—not through kidney dysfunction.

Multiple guidelines emphasize that serum creatinine production is affected by muscle mass, diet, and drugs 1. Creatine supplementation falls squarely into this category as a dietary factor that increases the creatinine generation rate without affecting actual glomerular filtration.

The Evidence on Renal Function

The most recent and highest quality meta-analysis from 2025 demonstrates that creatine supplementation causes a small increase in serum creatinine (0.07 µmol/L) but shows NO significant changes in glomerular filtration rate (GFR) 2. This is the critical finding: GFR remains unchanged, which is the actual measure of kidney function.

Breaking down the evidence by quality and recency:

  • 2025 meta-analysis 2: Modest creatinine increase (MD: 0.07 µmol/L), but GFR unchanged—indicating preserved kidney function
  • 2026 meta-analysis 3: Serum creatinine increased by 0.13 mg/dL, but urea and eGFR showed no differences between supplemented and control groups
  • 2020 randomized controlled trial 4: Used novel sensitive kidney injury biomarkers (KIM-1 and MCP-1) and found NO evidence of kidney damage despite creatinine increases

The 2020 study is particularly compelling because it employed kidney injury molecule-1 (KIM-1) and monocyte chemoattractant protein-1 (MCP-1)—sensitive biomarkers that detect actual kidney injury, not just metabolic changes 4. These remained normal despite creatinine elevation, definitively proving the creatinine rise is metabolic, not pathologic.

Clinical Interpretation Framework

Guidelines consistently warn that serum creatinine alone should not be used to assess kidney function 1. The 2007 International Society of Geriatric Oncology guidelines explicitly state that creatinine is "a difficult index to interpret" and "should not be used as a 'standalone' marker" 1.

When evaluating someone on creatine:

  • Expect creatinine to increase by 0.07-0.13 mg/dL (within normal reference ranges)
  • Monitor GFR/eGFR instead—this is the actual functional measure 5
  • Look for trends over time rather than absolute values 5
  • Consider the clinical context: A stable elevated creatinine with normal GFR is benign 5

Important Caveats

Do not use creatine supplementation in individuals with pre-existing renal disease, diabetes, hypertension, or reduced GFR 6. The safety data applies specifically to healthy individuals with normal baseline kidney function.

The 2018 guideline on renal monitoring notes that drugs like trimethoprim can spuriously elevate creatinine by blocking tubular secretion 5. Creatine works through a different mechanism (increased substrate for creatinine production), but the principle remains: not all creatinine elevations indicate kidney dysfunction.

Duration Considerations

The 2025 meta-analysis subgroup analysis revealed that creatinine elevation was significant at ≤1 week and >12 weeks, but not at 1-12 weeks 2. This suggests an initial metabolic adjustment period and a later steady-state elevation, both unrelated to kidney damage since GFR remained stable throughout.

Bottom line: Monitor GFR/eGFR, not isolated creatinine values, when assessing kidney function in creatine users. The creatinine increase is an expected metabolic consequence, not a red flag for renal impairment 2, 4, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.